514 related articles for article (PubMed ID: 19730788)
21. Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy.
Hagiya H; Miyake T; Kokumai Y; Murase T; Kuroe Y; Nojima H; Sugiyama J; Naito H; Hagioka S; Morimoto N
J Infect Chemother; 2013 Apr; 19(2):342-7. PubMed ID: 22965844
[TBL] [Abstract][Full Text] [Related]
22. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
Meersseman W; Lagrou K; Maertens J; Wilmer A; Hermans G; Vanderschueren S; Spriet I; Verbeken E; Van Wijngaerden E
Am J Respir Crit Care Med; 2008 Jan; 177(1):27-34. PubMed ID: 17885264
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
Del Bono V; Mularoni A; Furfaro E; Delfino E; Rosasco L; Miletich F; Viscoli C
Clin Vaccine Immunol; 2009 Oct; 16(10):1524-6. PubMed ID: 19692624
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic failure in a renal transplant patient with Pneumocystis jiroveci pneumonia: a case report.
Archontoulis NK; Staikou CV
Exp Clin Transplant; 2009 Jun; 7(2):129-32. PubMed ID: 19715519
[TBL] [Abstract][Full Text] [Related]
25. Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1-->3)-beta-D-glucan in clinical specimens.
Khan ZU; Ahmad S; Mokaddas E; Said T; Nair MP; Halim MA; Nampoory MR; McGinnis MR
J Med Microbiol; 2007 Jan; 56(Pt 1):129-132. PubMed ID: 17172527
[TBL] [Abstract][Full Text] [Related]
26. [Pneumocystis pneumonia in newborns: a challenge in contemporary intensive care].
Kordek A; Kołodziejczyk L; Pawlus B; Łoniewska B; Kuźna-Grygiel W; Rudnicki J
Ann Acad Med Stetin; 2006; 52(2):65-70; discussion 70. PubMed ID: 17633398
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
Ahmad S; Khan ZU; Theyyathel AM
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
[TBL] [Abstract][Full Text] [Related]
28. Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.
Baumann S; Reinwald M; Haghi D; Hofmann WK; Buchheidt D
Onkologie; 2013; 36(10):582-4. PubMed ID: 24107913
[TBL] [Abstract][Full Text] [Related]
29. Use of a serum beta-glucan assay for diagnosis of HIV-related Pneumocystis jiroveci pneumonia in patients with negative microscopic examination results.
Pisculli ML; Sax PE
Clin Infect Dis; 2008 Jun; 46(12):1928-30. PubMed ID: 18540807
[No Abstract] [Full Text] [Related]
30. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.
Presterl E; Parschalk B; Bauer E; Lassnigg A; Hajdu S; Graninger W
Int J Infect Dis; 2009 Nov; 13(6):707-12. PubMed ID: 19157947
[TBL] [Abstract][Full Text] [Related]
31. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.
Trof RJ; Beishuizen A; Debets-Ossenkopp YJ; Girbes AR; Groeneveld AB
Intensive Care Med; 2007 Oct; 33(10):1694-703. PubMed ID: 17646966
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.
Onishi A; Sugiyama D; Kogata Y; Saegusa J; Sugimoto T; Kawano S; Morinobu A; Nishimura K; Kumagai S
J Clin Microbiol; 2012 Jan; 50(1):7-15. PubMed ID: 22075593
[TBL] [Abstract][Full Text] [Related]
33. Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis jiroveci infection in orthotopic liver transplantation.
Almaslmani M; Derbala MF; Albozom I; Khattab M; Chacko K; Alani A
Transpl Infect Dis; 2008 Oct; 10(5):339-42. PubMed ID: 18248564
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of (1-->3)-beta-d-glucan in a patient with invasive sino-orbital aspergillosis.
Nakanishi W; Fujishiro Y; Nishimura S; Fukaya T
Auris Nasus Larynx; 2009 Apr; 36(2):224-7. PubMed ID: 18650040
[TBL] [Abstract][Full Text] [Related]
35. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
36. [Pneumocystis carinii and aspergillus pneumonia in immunosuppression in rapidly progressing glomerulonephritis of the anti-glomerular basement membrane type].
Späth M; Schollmeyer P
Med Klin (Munich); 1996 Sep; 91(9):603-6. PubMed ID: 8984320
[No Abstract] [Full Text] [Related]
37. Usefulness of (1→3)β-D glucan in early diagnosing Pneumocystis jirovecii pneumonia: a case report.
Atalay MA; Koc AN; Kaynar LG; Inci M; Kasap Tekinsen FF; Eser B
Infez Med; 2014 Mar; 22(1):57-61. PubMed ID: 24651093
[TBL] [Abstract][Full Text] [Related]
38. Comparison of PCR, (1-->3)-beta-D-glucan and galactomannan assays in sera of rats with experimental invasive aspergillosis.
Hashimoto A; Yamakami Y; Kamberi P; Yamagata E; Karashima R; Nagaoka H; Nasu M
J Clin Lab Anal; 1998; 12(5):257-62. PubMed ID: 9773954
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the galactomannan assay for the diagnosis of invasive aspergillosis in an animal model].
Zhao BL; Wen YT; Lü PH; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Nov; 30(11):839-43. PubMed ID: 18269845
[TBL] [Abstract][Full Text] [Related]
40. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
Xie LP; Liu T; Meng WT; Zhou J
Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
